# Dong-Wan Kim, M.D., Ph.D. Seoul National University Hospital – FDA Inspection, Nov 18, 2016

Source: https://www.keypedia.com/records/fda_inspections/dong-wan-kim-md-phd-seoul-national-university-hospital/11398e8b-6aeb-43cd-88ee-7fa147f2d373
Source feed: FDA_Inspections

> FDA inspection 995342 of Dong-Wan Kim, M.D., Ph.D. Seoul National University Hospital, November 18, 2016. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 995342
- Company Name: Dong-Wan Kim, M.D., Ph.D. Seoul National University Hospital
- Inspection Date: 2016-11-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 874163 - 2014-03-26
- FDA Inspection 728638 - 2011-05-20

## Related Officers

- [Byungja E. Marciante](https://www.keypedia.com/people/byungja-e-marciante/5d1f2927-9017-4ab6-8ad2-521e340ef14f)

Company: https://www.keypedia.com/companies/dong-wan-kim-md-phd-seoul-national-university-hospital/2fc2b158-6586-4881-a045-12957852842a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c